Medicare Enrolled
Dr. Michael Novak, MD
Neurology · Naples, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Novak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Novak? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Novak
Dr. Michael Novak is a neurology in Naples, FL, with 20 years in practice. Based on federal Medicare data, Dr. Novak performed 121,019 Medicare services across 2,185 unique beneficiaries.
Between the years covered by Open Payments, Dr. Novak received a total of $13,465 from 70 pharmaceutical and/or device companies across 813 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Novak is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 0% volume in FL$ $13,465 industry payments
Medicare Practice Summary
Medicare Utilization ↗121,019
Medicare services
Top 0% in FL for neurology
2,185
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,051 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit | 111,046 | $5 | $8 |
| MRI contrast dye injection (gadobutrol) | 7,025 | $0 | $2 |
| Office visit, established patient (30-39 min) | 812 | $95 | $250 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 380 | $127 | $376 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 249 | $79 | $207 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 166 | $61 | $128 |
| Office visit, established patient (20-29 min) | 144 | $65 | $169 |
| Office visit, established patient, complex (40-54 min) | 124 | $138 | $337 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 100 | $158 | $696 |
| Mri scan of blood vessels of head without contrast | 93 | $162 | $1,326 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 77 | $144 | $438 |
| Mri scan of brain without contrast | 62 | $156 | $1,255 |
| Mri scan of lower spinal canal without contrast | 62 | $154 | $1,135 |
| Nerve conduction, 5-6 studies | 59 | $106 | $331 |
| New patient office visit, complex (60-74 min) | 57 | $164 | $488 |
| Injection of chemical for paralysis of nerve muscles on side of face | 54 | $135 | $730 |
| New patient office visit (45-59 min) | 54 | $108 | $440 |
| Nerve conduction, 7-8 studies | 48 | $140 | $436 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 45 | $42 | $150 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 41 | $18 | $47 |
| Mri scan of upper spinal canal without contrast | 40 | $153 | $1,134 |
| Mri scan of blood vessels of neck before and after contrast | 39 | $282 | $2,075 |
| Injection, methylprednisolone acetate, 80 mg | 39 | $9 | $15 |
| Nerve conduction, 9-10 studies | 33 | $170 | $528 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, each additional extremity | 29 | $103 | $233 |
| Injection of trigger points, 3 or more muscles | 25 | $49 | $146 |
| Nerve conduction, 3-4 studies | 23 | $90 | $276 |
| Injection of trigger points, 1-2 muscles | 22 | $42 | $130 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 21 | $1 | $10 |
| Mri scan of brain before and after contrast | 20 | $263 | $1,760 |
| Injection, ketorolac tromethamine, per 15 mg | 19 | $0 | $12 |
| Mri scan of blood vessels of neck without contrast | 11 | $181 | $1,324 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,465
Total received (2018-2024)
Avg $1,924/year across 7 years
Top 22% in FL for neurology
70
Companies
813
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,346 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$119 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,254
2023$2,085
2022$2,327
2021$2,063
2020$1,429
2019$1,409
2018$1,897
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$2,274
Teva Pharmaceuticals USA, Inc.
$1,065
Amgen Inc.
$798
Sunovion Pharmaceuticals Inc.
$703
Lilly USA, LLC
$606
Allergan, Inc.
$553
UCB, Inc.
$529
Supernus Pharmaceuticals, Inc.
$477
AbbVie Inc.
$465
Biogen, Inc.
$453
Avanir Pharmaceuticals, Inc.
$391
PFIZER INC.
$360
Lundbeck LLC
$347
Novartis Pharmaceuticals Corporation
$312
Biohaven Pharmaceuticals, Inc.
$252
Biohaven Pharmaceutical Holding Company Ltd.
$231
Neurocrine Biosciences, Inc.
$212
Eisai Inc.
$189
ACADIA Pharmaceuticals Inc
$184
Octapharma USA, Inc.
$171
EMD Serono, Inc.
$167
ARGENX US, INC.
$164
Acorda Therapeutics, Inc
$161
Alexion Pharmaceuticals, Inc.
$160
Otsuka America Pharmaceutical, Inc.
$156
Celgene Corporation
$138
E.R. Squibb & Sons, L.L.C.
$129
Horizon Therapeutics plc
$121
SCILEX PHARMACEUTICALS INC.
$120
Alnylam Pharmaceuticals Inc.
$96
UPSHER-SMITH LABORATORIES LLC
$96
Amneal Pharmaceuticals LLC
$93
Allergan Inc.
$86
Merz North America, Inc.
$72
GENZYME CORPORATION
$67
Merz Pharmaceuticals, LLC
$64
CSL Behring
$60
SK Life Science, Inc.
$58
Ipsen Biopharmaceuticals, Inc
$58
REVANCE THERAPEUTICS, INC.
$55
Grifols USA, LLC
$51
Mallinckrodt Hospital Products Inc.
$44
TerSera Therapeutics LLC
$42
Neurelis, Inc.
$42
JAZZ PHARMACEUTICALS INC.
$40
Janssen Pharmaceuticals, Inc
$37
Upsher-Smith Laboratories LLC
$37
Boston Scientific Corporation
$36
Genentech USA, Inc.
$36
US WorldMeds, LLC
$35
Kyowa Kirin, Inc.
$33
Promius Pharma LLC
$32
Takeda Pharmaceuticals U.S.A., Inc.
$31
CATALYST PHARMACEUTICALS, INC.
$27
Xeris Pharmaceuticals, Inc.
$24
Corium, LLC
$21
Sumitomo Pharma America, Inc.
$20
Avion Pharmaceuticals
$20
Saol Therapeutics Inc.
$19
ARBOR PHARMACEUTICALS, INC.
$17
Almatica Pharma LLC
$14
Mallinckrodt LLC
$14
Assertio Therapeutics, Inc.
$14
GE HEALTHCARE
$14
Medtronic USA, Inc.
$13
Currax Pharmaceuticals LLC
$12
Mitsubishi Tanabe Pharma America, Inc.
$12
Jazz Pharmaceuticals Inc.
$12
Zyla Life Sciences, Inc.
$11
Egalet US Inc
$11
Top 3 companies account for 30.7% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Briviact · CAMBIA · CONTRAVE · CREXONT · DAXXIFY · DUOPA · DYSPORT · Dhivy · Dysport · EMGALITY · Evrysdi · FIRDAPSE · GAMMAGARD · GILENYA · GRALISE · Gamunex-C · Hizentra · Horizant · INBRIJA · INGREZZA · INVOKANA · KESIMPTA · KEVEYIS · KISUNLA · LYRICA · Leqembi · MAYZENT · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · ONZETRA Xsail · OXTELLAR XR · Ongentys · PANZYGA · QMIIZ ODT · QULIPTA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPRIX · SUNOSI · Soliris · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XEOMIN · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $11 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
193
Per 100K population
49.8
County median income
$86,173
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
5.2 mi
5.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Novak is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Novak experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Novak performed 111,046 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Novak receive payments from pharmaceutical companies?
Yes. Dr. Novak received a total of $13,465 from 70 companies across 813 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Novak's costs compare to other neurologys in Naples?
Dr. Novak's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Novak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Naples
Browse neurologys in Naples ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in FL
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in FL
Which FL neurologys receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology